EUVIMEDEUVIMED entdecken
Übersichtsarbeit

How to identify patients with low-risk acute pulmonary embolism: clinical implications and knowledge gaps

Bartosz Karolak iD, Piotr Pruszczyk iD, Michał Ciurzyński iD

Cardiology Journal · 05.02.2026 · 33

DOI: 10.5603/cj.112596 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiology Journal, online erschienen am 05.02.2026. Verfasst von Bartosz Karolak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Cardiology, Infant Jesus Clinical Hospital, University Clinical Centre, Medical University of Warsaw, Poland. b.k…. Hauptthemen laut MEDLINE: Pulmonary Embolism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute pulmonary embolism (APE) is a common disease, affecting 75–269 out of 100,000 people each year. The clinical spectrum of APE is broad, ranging from asymptomatic or mild dyspnea to shock and cardiac arrest. A significant number of patients could be treated on an outpatient basis; however, there are no clear criteria for selecting individuals who could be safely treated at home. Although there is evidence of the safety and effectiveness of selection for home treatment based on the simplified Pulmonary Embolism Severity Index (sPESI) or the Hestia criteria, further analyses showed the benefits of combining these criteria with assessment of right ventricular dysfunction (RVD) on imaging and laboratory biomarker testing (troponins and N-terminal pro-B-type natriuretic peptide [NT-proBNP]). Another issue that should not be neglected is the assessment of bleeding risk associated with anticoagulant treatment initiation. This state-of-the-art review provides a comprehensive overview of risk stratification in patients with APE, focusing particularly on low-risk patients who can be safely treated at home.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismHumansRisk AssessmentAcute DiseaseBiomarkersRisk FactorsAnticoagulantsSeverity of Illness Index

Stichwörter der Autor:innen

biomarkersclinical prediction rulespulmonary embolismrisk stratification

Substanzen

BiomarkersAnticoagulants

Autor:innen und Institutionen

  • Department of Internal Medicine and Cardiology, Infant Jesus Clinical Hospital, University Clinical Centre, Medical University of Warsaw, Poland. b.karolak92@gmail.com.
  • Department of Internal Medicine and Cardiology, Infant Jesus Clinical Hospital, University Clinical Centre, Medical University of Warsaw, Poland.

ORCID-Profile: Bartosz Karolak, Piotr Pruszczyk, Michał Ciurzyński

Zitieren

APA

Karolak, B., Pruszczyk, P., & Ciurzyński, M. (2026). How to identify patients with low-risk acute pulmonary embolism: clinical implications and knowledge gaps. Cardiology Journal, 33(0). https://doi.org/10.5603/cj.112596

Vancouver

Karolak B, Pruszczyk P, Ciurzyński M. How to identify patients with low-risk acute pulmonary embolism: clinical implications and knowledge gaps. Cardiology Journal. 2026;33(0). doi:10.5603/cj.112596

BibTeX
@article{Karolak2026,
  author = {Karolak, Bartosz and Pruszczyk, Piotr and Ciurzyński, Michał},
  title = {How to identify patients with low-risk acute pulmonary embolism: clinical implications and knowledge gaps},
  journal = {Cardiology Journal},
  year = {2026},
  volume = {33},
  number = {0},
  doi = {10.5603/cj.112596}
}
Kostenlos starten →